1. Home
  2. ZLAB vs CXAIW Comparison

ZLAB vs CXAIW Comparison

Compare ZLAB & CXAIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zai Lab Limited

ZLAB

Zai Lab Limited

HOLD

Current Price

$25.00

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Logo CXApp Inc. Warrant

CXAIW

CXApp Inc. Warrant

N/A

Current Price

$0.03

Market Cap

0.0

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
ZLAB
CXAIW
Founded
2013
N/A
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
N/A
IPO Year
2017
2020

Fundamental Metrics

Financial Performance
Metric
ZLAB
CXAIW
Price
$25.00
$0.03
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
★ $49.60
N/A
AVG Volume (30 Days)
★ 766.5K
14.7K
Earning Date
05-07-2026
03-21-2025
Dividend Yield
N/A
N/A
EPS Growth
★ 38.46
N/A
EPS
N/A
★ N/A
Revenue
★ $460,156,000.00
$4,583,000.00
Revenue This Year
$9.75
N/A
Revenue Next Year
$26.03
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 15.33
N/A
52 Week Low
$15.96
$0.02
52 Week High
$34.72
$0.12

Technical Indicators

Market Signals
Indicator
ZLAB
CXAIW
Relative Strength Index (RSI) 49.96 39.78
Support Level $24.81 $0.03
Resistance Level $25.28 $0.04
Average True Range (ATR) 0.77 0.00
MACD -0.14 0.00
Stochastic Oscillator 41.43 89.00

Price Performance

Historical Comparison
ZLAB
CXAIW

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.

About CXAIW CXApp Inc. Warrant

CXApp Inc is a provider of AI-powered employee experience solutions, delivering enterprise-grade software that enhances workplace engagement, productivity, and operational efficiency. Its cloud-based, mobile-first platform integrates artificial intelligence, automation, and real-time analytics to streamline workplace interactions across people, spaces, and technology. The company's flagship product, the CXAI Platform, provides a comprehensive suite of tools designed to empower employees and enable organizations to create smarter workplaces. The product's key components include CXAI Apps, CXAI BTS, Agentic AI Capabilities, and CXAI-VU. The company generates the majority of its revenue from Licenses.

Share on Social Networks: